Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurren...
Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Purpose
Gemcitabine, cisplatin, and S‐1 chemotherapy was superior to gemcitabine and cisplatin chemotherapy for progression‐free survival and overall survival for unresectable and recurrent biliary tract cancer in a randomized phase III trial (KHBO1401). This study aimed to evaluate the outcome of conversion surgery after chemotherapy in biliary...
Alternative Titles
Full title
Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a82617ae42c94aab918ef237a4d2e2aa
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a82617ae42c94aab918ef237a4d2e2aa
Other Identifiers
ISSN
2475-0328
E-ISSN
2475-0328
DOI
10.1002/ags3.12713
